Rapid risk assessment: Risk related to the use of ‘do-it-yourself' CRISPR-associated gene engineering kit contaminated with pathogenic bacteria
On 24 March 2017, the German authorities reported the contamination of a ‘do-it-yourself’ bacterial gene engineering CRISPR kit produced in the US. The kit was contaminated with pathogenic bacteria (risk group 2), including some bacteria that are multidrug-resistant and ESBL-producing. The risk of infection by the contaminating strains in the kit is low for the users of the kit, assuming that they are healthy people. The contribution of the kit to the burden of antimicrobial resistance in the EU/EEA population and environment is marginal, and the risk associated with the kits is considered very low.
Rapid risk assessment: Multidrug-resistant Staphylococcus epidermidis
8 Nov 2018 - This rapid risk assessment addresses the public health risk associated with a previously unrecognised international spread of near pandrug-resistant strains of S. epidermidis as a cause of infection in several countries including EU Member States.
Rapid risk assessment: Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 in travellers previously hospitalised in Gran Canaria, Spain
11 Jul 2018 - This rapid risk assessment evaluates the risk of transmission and further spread of OXA-48-producing Klebsiella pneumonia e ST392 from travellers having sought medical care in Gran Canaria to healthcare facilities in their country of origin in the EU/EEA.
Rapid risk assessment: Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae
13 Jun 2018 - This risk assessment will discuss CAZ-AVI resistance in brief, review the recent literature reporting resistance of CRE to CAZ-AVI, and assess the risk for the EU/EEA countries.